Literature DB >> 28636599

Addendum: Immune clearance of highly pathogenic SIV infection.

Scott G Hansen, Michael Piatak, Abigail B Ventura, Colette M Hughes, Roxanne M Gilbride, Julia C Ford, Kelli Oswald, Rebecca Shoemaker, Yuan Li, Matthew S Lewis, Awbrey N Gilliam, Guangwu Xu, Nathan Whizin, Benjamin J Burwitz, Shannon L Planer, John M Turner, Alfred W Legasse, Michael K Axthelm, Jay A Nelson, Klaus Früh, Jonah B Sacha, Jacob D Estes, Brandon F Keele, Paul T Edlefsen, Jeffrey D Lifson, Louis J Picker.   

Abstract

This corrects the article DOI: 10.1038/nature12519.

Entities:  

Year:  2017        PMID： 28636599     DOI： 10.1038/nature22984

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


  2 in total

1.  Synthesis of oligodeoxyribonucleotides containing degenerate bases and their use as primers in the polymerase chain reaction.

Authors:  P K Lin; D M Brown
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

2.  Immune clearance of highly pathogenic SIV infection.

Authors:  Scott G Hansen; Michael Piatak; Abigail B Ventura; Colette M Hughes; Roxanne M Gilbride; Julia C Ford; Kelli Oswald; Rebecca Shoemaker; Yuan Li; Matthew S Lewis; Awbrey N Gilliam; Guangwu Xu; Nathan Whizin; Benjamin J Burwitz; Shannon L Planer; John M Turner; Alfred W Legasse; Michael K Axthelm; Jay A Nelson; Klaus Früh; Jonah B Sacha; Jacob D Estes; Brandon F Keele; Paul T Edlefsen; Jeffrey D Lifson; Louis J Picker
Journal:  Nature       Date:  2013-09-11       Impact factor: 49.962
  2 in total
  30 in total

1.  Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression.

Authors:  José M Martinez-Navio; Sebastian P Fuchs; Shara N Pantry; William A Lauer; Natasha N Duggan; Brandon F Keele; Eva G Rakasz; Guangping Gao; Jeffrey D Lifson; Ronald C Desrosiers
Journal:  Immunity       Date:  2019-03-05       Impact factor: 31.745

2.  Intragastric Administration of Lactobacillus plantarum and 2,2'-Dithiodipyridine-Inactivated Simian Immunodeficiency Virus (SIV) Does Not Protect Indian Rhesus Macaques from Intrarectal SIV Challenge or Reduce Virus Replication after Transmission.

Authors:  Diane G Carnathan; Joseph J Mackel; Shelby L Sweat; Chiamaka A Enemuo; Etse H Gebru; Pallavi Dhadvai; Sailaja Gangadhara; Sakeenah Hicks; Thomas H Vanderford; Rama R Amara; José Esparza; Wei Lu; Jean-Marie Andrieu; Guido Silvestri
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

3.  TLR7 agonist administration to SIV-infected macaques receiving early initiated cART does not induce plasma viremia.

Authors:  Gregory Q Del Prete; W Gregory Alvord; Yuan Li; Claire Deleage; Mukta Nag; Kelli Oswald; James A Thomas; Cathi Pyle; William J Bosche; Vicky Coalter; Adam Wiles; Rodney Wiles; Brian Berkemeier; Michael Hull; Elizabeth Chipriano; Lorna Silipino; Randy Fast; Jacob Kiser; Rebecca Kiser; Tyler Malys; Joshua Kramer; Matthew W Breed; Charles M Trubey; Jacob D Estes; Tiffany L Barnes; Joseph Hesselgesser; Romas Geleziunas; Jeffrey D Lifson
Journal:  JCI Insight       Date:  2019-06-06

4.  CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.

Authors:  Afam A Okoye; Derick D Duell; Yoshinori Fukazawa; Benjamin Varco-Merth; Alejandra Marenco; Hannah Behrens; Morgan Chaunzwa; Andrea N Selseth; Roxanne M Gilbride; Jason Shao; Paul T Edlefsen; Romas Geleziunas; Mykola Pinkevych; Miles P Davenport; Kathleen Busman-Sahay; Michael Nekorchuk; Haesun Park; Jeremy Smedley; Michael K Axthelm; Jacob D Estes; Scott G Hansen; Brandon F Keele; Jeffery D Lifson; Louis J Picker
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

5.  Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapy.

Authors:  Adrienne E Swanstrom; Taina T Immonen; Kelli Oswald; Cathi Pyle; James A Thomas; William J Bosche; Lorna Silipino; Michael Hull; Laura Newman; Vicky Coalter; Adam Wiles; Rodney Wiles; Jacob Kiser; David R Morcock; Rebecca Shoemaker; Randy Fast; Matthew W Breed; Joshua Kramer; Duncan Donohue; Tyler Malys; Christine M Fennessey; Charles M Trubey; Claire Deleage; Jacob D Estes; Jeffrey D Lifson; Brandon F Keele; Gregory Q Del Prete
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

6.  A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge.

Authors:  Scott G Hansen; Emily E Marshall; Daniel Malouli; Abigail B Ventura; Colette M Hughes; Emily Ainslie; Julia C Ford; David Morrow; Roxanne M Gilbride; Jin Y Bae; Alfred W Legasse; Kelli Oswald; Rebecca Shoemaker; Brian Berkemeier; William J Bosche; Michael Hull; Jennie Womack; Jason Shao; Paul T Edlefsen; Jason S Reed; Ben J Burwitz; Jonah B Sacha; Michael K Axthelm; Klaus Früh; Jeffrey D Lifson; Louis J Picker
Journal:  Sci Transl Med       Date:  2019-07-17       Impact factor: 17.956

7.  CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.

Authors:  Justin Harper; Shari Gordon; Chi Ngai Chan; Hong Wang; Emily Lindemuth; Cristin Galardi; Shane D Falcinelli; Samuel L M Raines; Jenna L Read; Kevin Nguyen; Colleen S McGary; Michael Nekorchuk; Kathleen Busman-Sahay; James Schawalder; Colin King; Maria Pino; Luca Micci; Barbara Cervasi; Sherrie Jean; Andrew Sanderson; Brian Johns; A Alicia Koblansky; Heather Amrine-Madsen; Jeffrey Lifson; David M Margolis; Guido Silvestri; Katharine J Bar; David Favre; Jacob D Estes; Mirko Paiardini
Journal:  Nat Med       Date:  2020-03-16       Impact factor: 53.440

8.  Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody.

Authors:  Mangaiarkarasi Asokan; Joana Dias; Cuiping Liu; Anna Maximova; Keenan Ernste; Amarendra Pegu; Krisha McKee; Wei Shi; Xuejun Chen; Cassandra Almasri; Wanwisa Promsote; David R Ambrozak; Lucio Gama; Jianfei Hu; Daniel C Douek; John-Paul Todd; Jeffrey D Lifson; Slim Fourati; Rafick P Sekaly; Andrew R Crowley; Margaret E Ackerman; Sung Hee Ko; Divya Kilam; Eli A Boritz; Laura E Liao; Katharine Best; Alan S Perelson; John R Mascola; Richard A Koup
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-20       Impact factor: 11.205

9.  Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.

Authors:  Afam A Okoye; Scott G Hansen; Mukta Vaidya; Yoshinori Fukazawa; Haesun Park; Derick M Duell; Richard Lum; Colette M Hughes; Abigail B Ventura; Emily Ainslie; Julia C Ford; David Morrow; Roxanne M Gilbride; Alfred W Legasse; Joseph Hesselgesser; Romas Geleziunas; Yuan Li; Kelli Oswald; Rebecca Shoemaker; Randy Fast; William J Bosche; Bhavesh R Borate; Paul T Edlefsen; Michael K Axthelm; Louis J Picker; Jeffrey D Lifson
Journal:  Nat Med       Date:  2018-08-06       Impact factor: 53.440

10.  SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.

Authors:  Amir Dashti; Chevaughn Waller; Maud Mavigner; Nils Schoof; Katharine J Bar; George M Shaw; Thomas H Vanderford; Shan Liang; Jeffrey D Lifson; Richard M Dunham; Guido Ferrari; Marina Tuyishime; Chia-Ying K Lam; Jeffrey L Nordstrom; David M Margolis; Guido Silvestri; Ann Chahroudi
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.